NCT05761886Completed
Rural Area Pharmacist Intervention for Diabetes
Rural Area Pharmacist Intervention for Diabetes - Management Using eHealth: A Pilot Study (RAPID-ME)
Source: ClinicalTrials.gov · Last updated 27 Apr 2025
Brief summary (registry, in English)
The goal of the project is to inform the system leaders regarding the feasibility and utility of having an embedded telehealth-based clinical pharmacist at rural primary care practices for supportive disease management of patients with Type 2 diabetes (T2D) and whether continuing and expanding the program within the system is worthwhile.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 87 (actual)
- First submitted
- 27 Feb 2023
- Start date
- 16 May 2023
- Primary completion date
- 12 Oct 2024
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Type 2 diabetes
- NCT number
- NCT05761886
What you commit to
- Study type: Interventional
- Participants enrolled: 87
- From 16 May 2023 to the primary completion date, 12 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those receiving T2D care from an endocrinologist
- Those receiving long term, hospice, or palliative care services
Other illness
- Patients with gestational or type 1 diabetes
- Those enrolled in any other chronic disease management programs delivered by non-physician healthcare professionals
- Those with serious mental illnesses (schizophrenia and other psychotic disorders, major depressive disorders, bipolar disorders, and borderline personality disorder)
- Those with malignant cancer
- Those with cognitive impairment
Who the study is looking for
- Age \>= 18 years and \<=75 years (since children have different incidence, management, and outcomes of Type 2 diabetes (T2D) compared to adults and older adults aged more than 75 years may have had their hemoglobin A1C (HbA1c) goals adjusted to higher thresholds)
- HbA1c reading ≥ 8% recorded during 6 months prior to or up to 9 days after the encounter at the participating practices
- Uncontrolled type 2 diabetes (ICD-10-CM code E11.XX) recorded in the EHR in the year prior to up to 1 week after the uncontrolled HbA1c reading
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wake Forest University Health Sciences Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.